- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07663708
4-STEP-Training Program for Doomscrolling, Cyberchondriac Behavior and Psychiatric Symptoms (4-STEP-TPS) Among Individuals With Social Media Addiction ((4-STEP-TPS))
Effectiveness of 4-Step Training Program for Doomscrolling, Cyberchondriac Behavior and Psychiatric Symptoms Among Individuals With Social Media Addiction: A Randomized Trial
Panoramica dello studio
Stato
Intervento / Trattamento
Descrizione dettagliata
In this research, a sample of approximately N = 300 young adults will be initially enrolled for eligibility screening from public and private universities in Faisalabad and Sahiwal, Pakistan, using purposive sampling techniques. Participants will be aged between 18 and 28 years and will have no history of severe physical, psychiatric, or psychological disorders. After eligibility assessment and screening based on standardized measures, N = 80 participants will be selected and randomly allocated to the experimental and waitlist control groups.
This study is expected to provide valuable evidence for mental health practitioners regarding effective interventions for managing social media addiction among young adults. The 4-STEP Training Program is anticipated to enhance participants' awareness and understanding of problematic digital behaviors, including doomscrolling and cyberchondriac behavior. The intervention is also expected to reduce depressive symptoms and health anxiety, improve self-regulation and promote healthier digital habits. Furthermore, the program is expected to enhance psychological well-being, academic functioning, and overall productivity while significantly reducing levels of social media addiction.
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Qasir Abbas, PhD Clinical Psychology
- Numero di telefono: 923337683133
- Email: qasirabbas47@yahoo.com
Backup dei contatti dello studio
- Nome: Atika Shafi, MS Clinical Psychology
Luoghi di studio
-
-
Punjab Province
-
Faisalabad, Punjab Province, Pakistan, 38000
- Government College University Faisalabad
-
Contatto:
- Qasir Abbas, PhD Clinical Psychology
- Numero di telefono: 923337683133
- Email: qasirabbas47@yahoo.com
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Age range: 18-29 years
- No physical, psychiatric, or psychological conditions
- Minimum score of 84 on the Social Networking Addiction Scale (SNAS)
- Minimum score of 23 on the Cyberchondria Severity Scale (CSS-12)
Exclusion Criteria:
- Age below 18 or above 29 years
- Presence of any physical, psychiatric, or psychological conditions
- Score below 84 on the Social Networking Addiction Scale (SNAS)
- Score below 23 on the Cyberchondria Severity Scale (CSS-12)
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Nessun intervento: Gruppo di controllo
Nessun intervento
|
|
|
Sperimentale: Gruppo sperimentale: setting individuale
Programma di allenamento in 4 FASI in modalità 1-1
|
4 Modules with 1 Module being delivered in 1 weekly session of approximately 90 minutes.
The details of each module/step is described as follows: Step 1 (Module 1): S = Screening, Assessment and Psychoeducation: Involves screening and assessment of the problem, interpretation of the results, feedback and psychoeducation, identifying and breaking the resistance, motivation, and conceptualization.
Step 2 (Module 2): T = Treatment Conceptualization and Planning: Involves pattern identification, distortion identification, as well as pattern and distortions modifications.
Step 3 (Module 3): E = Effective Management Strategies: Involves management strategies to treat the earlier identified patterns as well as the implementation and confirmation of activities via a Pattern Schedule Chart.
Step 4 (Module 4): P = Prevention (Lapse-Relapse): Involves self-reflection and support building, monitoring and dependency check and slip plans and support additions
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Scala della dipendenza dai social network (SNAS)
Lasso di tempo: Allo screening, dopo 4 settimane, e alla rivalutazione fino a 6 mesi
|
La Social Networking Addiction Scale (SNAS) è stata sviluppata per misurare la dipendenza da tutte le forme di social networking attraverso sei dimensioni: salienza (item 1-4), modificazione dell'umore (item 5-7), tolleranza (item 8-10), astinenza (item 5-7). punti 11-14), conflitto (punti 15-17) e ricaduta (punti 18-21) (Shahnawaz & Rehman, 2020).
La SNAS è una scala auto-riportata che comprende 21 elementi valutati su una scala Likert a 7 punti che va da 1 (fortemente in disaccordo) a 7 (fortemente d'accordo).
Il punteggio può variare da 21 a 147.
Qualsiasi punteggio superiore a un punteggio totale di 84 indica dipendenza.
La scala ha dimostrato una buona affidabilità test-retest pari a 0,88 e una buona validità, come riportato da Shahnawaz e Rehman (2020).
|
Allo screening, dopo 4 settimane, e alla rivalutazione fino a 6 mesi
|
|
Cyberchondria Severity Scale (CSS-12)
Lasso di tempo: At screening, after 4 weeks, and reassessment up to 6 months
|
The Cyberchondria Severity Scale-12 (CSS-12), developed by Eoin McElroy et al. (2019), is a 12-item self-report measure assessing excessive, anxiety-provoking online health searches across four dimensions: compulsion, distress, excessiveness, and reassurance-seeking.
Items are rated on a 5-point Likert scale (1 = Never to 5 = Always), with total scores ranging from 12-60; higher scores indicate greater cyberchondria.
The scale is brief, reliable, and valid, suitable for both clinical and non-clinical populations, and widely used to evaluate problematic health-related online behavior.
|
At screening, after 4 weeks, and reassessment up to 6 months
|
|
Doomscrolling Scale (DS)
Lasso di tempo: At screening, after 4 weeks, and reassessment up to 6 months
|
The Doomscrolling Scale was developed to assess compulsive engagement with negative online news content and excessive scrolling behavior, particularly during times of crisis (Sharma et al., 2022).
The scale measures three core dimensions: obsessive news consumption, emotional distress, and behavioral compulsion.
It is a self-report instrument consisting of 15 items rated on a 5-point Likert scale ranging from 1 (never) to 5 (always).
The total score is calculated by summing all item responses, with higher scores indicating greater levels of doomscrolling behavior.
The scale has demonstrated good internal consistency (Cronbach's α = 0.88) and satisfactory construct validity (Sharma et al., 2022).
|
At screening, after 4 weeks, and reassessment up to 6 months
|
|
Short Health Anxiety Inventory (SHAI)
Lasso di tempo: At screening, after 4 weeks, and reassessment up to 6 months
|
The Short Health Anxiety Inventory (SHAI) was developed to assess health-related anxiety and preoccupation with physical symptoms, independent of actual medical status (Salkovskis et al., 2002).
The scale measures two main dimensions: perceived likelihood of illness and perceived negative consequences of illness.
It is a self-report instrument consisting of 18 items, each presenting four response options scored from 0 to 3, reflecting increasing levels of health anxiety.
Total scores range from 0 to 54, with higher scores indicating greater levels of health anxiety.
The SHAI has demonstrated excellent internal consistency, with reported Cronbach's alpha values ranging from 0.86 to 0.95, and strong convergent and construct validity.
The HAI is a reliable and valid measure of health anxiety (Salkovskis et al., 2002).
|
At screening, after 4 weeks, and reassessment up to 6 months
|
|
Patient Health Questionnaire-9 (PHQ-9)
Lasso di tempo: At screening, after 4 weeks, and reassessment up to 6 months
|
The Patient Health Questionnaire-9 (PHQ-9) was developed to measure the severity of depressive symptoms based on the diagnostic criteria of major depressive disorder (Kroenke et al., 2001).
The scale assesses nine core symptoms of depression, including low mood, loss of interest, fatigue, sleep disturbances, appetite changes, concentration difficulties, feelings of worthlessness, psychomotor changes, and suicidal ideation.
The PHQ-9 is a self-report instrument consisting of 9 items rated on a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day).
Total scores range from 0 to 27, with higher scores indicating greater severity of depressive symptoms.
The Patient Health Questionnaire (PHQ) is a self-administered version of the PRIME-MD diagnostic instrument for common mental disorders(The PHQ-9 - Kroenke - 2001 - Journal of General Internal Medicine - Wiley Online Library, 2001).
|
At screening, after 4 weeks, and reassessment up to 6 months
|
Collaboratori e investigatori
Investigatori
- Investigatore principale: Qasir Abbas, PhD Clinical Psychology, Government College University Faisalabad
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- GCUF_CT_STP
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .